Advances in single-cell RNA sequencing and its applications in cancer research
© 2023. BioMed Central Ltd., part of Springer Nature..
Cancers are a group of heterogeneous diseases characterized by the acquisition of functional capabilities during the transition from a normal to a neoplastic state. Powerful experimental and computational tools can be applied to elucidate the mechanisms of occurrence, progression, metastasis, and drug resistance; however, challenges remain. Bulk RNA sequencing techniques only reflect the average gene expression in a sample, making it difficult to understand tumor heterogeneity and the tumor microenvironment. The emergence and development of single-cell RNA sequencing (scRNA-seq) technologies have provided opportunities to understand subtle changes in tumor biology by identifying distinct cell subpopulations, dissecting the tumor microenvironment, and characterizing cellular genomic mutations. Recently, scRNA-seq technology has been increasingly used in cancer studies to explore tumor heterogeneity and the tumor microenvironment, which has increased the understanding of tumorigenesis and evolution. This review summarizes the basic processes and development of scRNA-seq technologies and their increasing applications in cancer research and clinical practice.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Journal of hematology & oncology - 16(2023), 1 vom: 24. Aug., Seite 98 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Huang, Dezhi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Completed 25.08.2023 Date Revised 23.11.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13045-023-01494-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36111155X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36111155X | ||
| 003 | DE-627 | ||
| 005 | 20231226084444.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13045-023-01494-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM36111155X | ||
| 035 | |a (NLM)37612741 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Huang, Dezhi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advances in single-cell RNA sequencing and its applications in cancer research |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.08.2023 | ||
| 500 | |a Date Revised 23.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. BioMed Central Ltd., part of Springer Nature. | ||
| 520 | |a Cancers are a group of heterogeneous diseases characterized by the acquisition of functional capabilities during the transition from a normal to a neoplastic state. Powerful experimental and computational tools can be applied to elucidate the mechanisms of occurrence, progression, metastasis, and drug resistance; however, challenges remain. Bulk RNA sequencing techniques only reflect the average gene expression in a sample, making it difficult to understand tumor heterogeneity and the tumor microenvironment. The emergence and development of single-cell RNA sequencing (scRNA-seq) technologies have provided opportunities to understand subtle changes in tumor biology by identifying distinct cell subpopulations, dissecting the tumor microenvironment, and characterizing cellular genomic mutations. Recently, scRNA-seq technology has been increasingly used in cancer studies to explore tumor heterogeneity and the tumor microenvironment, which has increased the understanding of tumorigenesis and evolution. This review summarizes the basic processes and development of scRNA-seq technologies and their increasing applications in cancer research and clinical practice | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Heterogeneity | |
| 650 | 4 | |a Treatment | |
| 650 | 4 | |a Tumor microenvironment | |
| 650 | 4 | |a scRNA-seq | |
| 700 | 1 | |a Ma, Naya |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Xinlei |e verfasserin |4 aut | |
| 700 | 1 | |a Gou, Yang |e verfasserin |4 aut | |
| 700 | 1 | |a Duan, Yishuo |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Bangdong |e verfasserin |4 aut | |
| 700 | 1 | |a Xia, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Xianlan |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xiaoqi |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Qiong |e verfasserin |4 aut | |
| 700 | 1 | |a Rao, Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Xi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of hematology & oncology |d 2008 |g 16(2023), 1 vom: 24. Aug., Seite 98 |w (DE-627)NLM180433709 |x 1756-8722 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:1 |g day:24 |g month:08 |g pages:98 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13045-023-01494-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 1 |b 24 |c 08 |h 98 | ||